BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

682 related articles for article (PubMed ID: 34943685)

  • 1. Nanotechnology as a Novel Approach in Combating Microbes Providing an Alternative to Antibiotics.
    Mubeen B; Ansar AN; Rasool R; Ullah I; Imam SS; Alshehri S; Ghoneim MM; Alzarea SI; Nadeem MS; Kazmi I
    Antibiotics (Basel); 2021 Nov; 10(12):. PubMed ID: 34943685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimicrobial Effects of Biogenic Nanoparticles.
    Singh P; Garg A; Pandit S; Mokkapati VRSS; Mijakovic I
    Nanomaterials (Basel); 2018 Dec; 8(12):. PubMed ID: 30563095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanotechnology as a Promising Approach to Combat Multidrug Resistant Bacteria: A Comprehensive Review and Future Perspectives.
    Hetta HF; Ramadan YN; Al-Harbi AI; A Ahmed E; Battah B; Abd Ellah NH; Zanetti S; Donadu MG
    Biomedicines; 2023 Jan; 11(2):. PubMed ID: 36830949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nano-Strategies to Fight Multidrug Resistant Bacteria-"A Battle of the Titans".
    Baptista PV; McCusker MP; Carvalho A; Ferreira DA; Mohan NM; Martins M; Fernandes AR
    Front Microbiol; 2018; 9():1441. PubMed ID: 30013539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Harnessing the potential of bimetallic nanoparticles: Exploring a novel approach to address antimicrobial resistance.
    Bharti S
    World J Microbiol Biotechnol; 2024 Feb; 40(3):89. PubMed ID: 38337082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of microbial biofilms - the contribution of micro and nanostructured materials.
    Grumezescu AM; Chifiriuc CM
    Curr Med Chem; 2014; 21(29):3311. PubMed ID: 24606506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel Nanotherapeutics as Next-generation Anti-infective Agents: Current Trends and Future Prospectives.
    Subhaswaraj P; Syed A; Siddhardha B
    Curr Drug Discov Technol; 2020; 17(4):457-468. PubMed ID: 31309893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanoparticles: Alternatives Against Drug-Resistant Pathogenic Microbes.
    Rudramurthy GR; Swamy MK; Sinniah UR; Ghasemzadeh A
    Molecules; 2016 Jun; 21(7):. PubMed ID: 27355939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanomaterials for alternative antibacterial therapy.
    Hemeg HA
    Int J Nanomedicine; 2017; 12():8211-8225. PubMed ID: 29184409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanoparticles as therapeutic options for treating multidrug-resistant bacteria: research progress, challenges, and prospects.
    Mba IE; Nweze EI
    World J Microbiol Biotechnol; 2021 May; 37(6):108. PubMed ID: 34046779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanotechnology-driven strategies to enhance the treatment of drug-resistant bacterial infections.
    Zhang J; Liu M; Guo H; Gao S; Hu Y; Zeng G; Yang D
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2024; 16(3):e1968. PubMed ID: 38772565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of microbial growth by silver nanoparticles synthesized from Fraxinus xanthoxyloides leaf extract.
    Rafiq A; Zahid K; Qadir A; Khan MN; Khalid ZM; Ali N
    J Appl Microbiol; 2021 Jul; 131(1):124-134. PubMed ID: 33251642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential of Nanoparticles Integrated with Antibacterial Properties in Preventing Biofilm and Antibiotic Resistance.
    Thambirajoo M; Maarof M; Lokanathan Y; Katas H; Ghazalli NF; Tabata Y; Fauzi MB
    Antibiotics (Basel); 2021 Nov; 10(11):. PubMed ID: 34827276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tackling Threats and Future Problems of Multidrug-Resistant Bacteria.
    Medina E; Pieper DH
    Curr Top Microbiol Immunol; 2016; 398():3-33. PubMed ID: 27406189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent Advances in the Development of Lipid-, Metal-, Carbon-, and Polymer-Based Nanomaterials for Antibacterial Applications.
    Ren R; Lim C; Li S; Wang Y; Song J; Lin TW; Muir BW; Hsu HY; Shen HH
    Nanomaterials (Basel); 2022 Nov; 12(21):. PubMed ID: 36364631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanoparticles as Novel Emerging Therapeutic Antibacterial Agents in the Antibiotics Resistant Era.
    Fatima F; Siddiqui S; Khan WA
    Biol Trace Elem Res; 2021 Jul; 199(7):2552-2564. PubMed ID: 33030657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metallic Nanosystems in the Development of Antimicrobial Strategies with High Antimicrobial Activity and High Biocompatibility.
    Skłodowski K; Chmielewska-Deptuła SJ; Piktel E; Wolak P; Wollny T; Bucki R
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Review on Nano-Antimicrobials: Metal Nanoparticles, Methods and Mechanisms.
    Hoseinzadeh E; Makhdoumi P; Taha P; Hossini H; Stelling J; Kamal MA; Ashraf GM
    Curr Drug Metab; 2017; 18(2):120-128. PubMed ID: 27908256
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 35.